Tor McCaul – Managing Director – Comet Ridge Limited (ASX: COI) is a publicly listed Australian energy company focused on the development of natural ga
Copyright 2023 – Finance News Network
24 Nov 2020 - SUDA Pharmaceuticals Limited (ASX:SUD) Managing Director Dr Michael Baker discusses the company's technology to convert solid dose drugs into oral sprays and the outlook for the year ahead.
30 Jul 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses Phase III design for a trial in non-small cell lung cancer, positive results in head and neck cancer, and clearance for a Phase I study in autoimmune diseases.
19 Sep 2022 - Altech Chemicals Limited (ASX:ATC) Managing Director Iggy Tan discusses the advantages of the company's sodium alumina solid state batteries over lithium-ion batteries, and the roadmap ahead to commercialisation.
24 Oct 2019 - BluGlass Limited (ASX:BLG) Managing Director and CEO, Giles Bourne, discusses the launch of the company's new laser diode business and how this fits into its strategy.
31 Mar 2020 - BluGlass Limited (ASX:BLG) Managing Director and CEO,Giles Bourne, talks about the company's 1:1 non-renounceable rights issue, the need to fund its technology through to commercialisation, independent validation of its RPCVD technology and its response to COVID-19.
12 Aug 2022 - Magnis Energy Technologies Limited (ASX:MNS) Executive Chairman Frank Poullas discusses the pathway to revenues and increasing capacity as the company's battery gigafactory commences production.
16 Nov 2023 - Linius Technologies Limited (ASX:LNU) CEO and Executive Director James Brennan discusses the company's quarterly performance and its technology for rendering video files as flexible as other forms of data.
04 Jul 2022 - Magnetite Mines Limited (ASX:MGT) new board member Simon Wandke discusses his background, what he will bring to the company and the company's outlook.
13 Mar 2020 - SUDA Pharmaceuticals Limited (ASX:SUD) CEO, Dr Michael Baker talks 1H20 results progress with the company's lead product Zolpimist, the spay version of Sanofi’s blockbuster insomnia drug Ambien and focus for 2020.
12 Aug 2025 - CEO and Managing Director Mark Freeman and Portfolio Manager Brett McNeill discuss the FY25 full-year results of Djerriwarrh Investments (ASX:DJW).